| Literature DB >> 35984154 |
Bolin Liu1, Shujuan Liu2, Tao Zheng1, Dan Lu1, Lei Chen1, Tao Ma1, Yuan Wang3, Guodong Gao3, Shiming He1,2.
Abstract
Population aging is an unprecedented, multifactorial, and global process that poses significant challenges to healthcare systems. Enhanced recovery after surgery (ERAS) protocols aim to optimize perioperative care. The first neurosurgical ERAS protocol for elective craniotomy has contributed to a shortened postoperative hospital stay, accelerated functional recovery, improved patient satisfaction, and reduced medical care cost in adult patients aged 18 to 65 years compared with conventional perioperative care. However, ERAS protocols for geriatric patients over 65 years of age undergoing cranial surgery are lacking. In this paper, we propose a novel ERAS protocol for such patients by reviewing and summarizing the key elements of successful ERAS protocols/guidelines and optimal perioperative care for geriatric patients described in the literature, as well as our experience in applying the first neurosurgical ERAS protocol for a quality improvement initiative. This proposal aimed to establish an applicable protocol for geriatric patients undergoing elective craniotomy, with evidence addressing its feasibility, safety, and potential efficacy. This multimodal, multidisciplinary, and evidence-based ERAS protocol includes preoperative, intraoperative, and postoperative assessment and management as well as outcome measures. The implementation of the current protocol may hold promise in reducing perioperative morbidity, enhancing functional recovery, improving postoperative outcomes in geriatric patients scheduled for elective craniotomy, and serving as a stepping stone to promote further research into the advancement of geriatric patient care.Entities:
Mesh:
Year: 2022 PMID: 35984154 PMCID: PMC9388027 DOI: 10.1097/MD.0000000000030043
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
ERAS protocol for geriatric patients undergoing elective craniotomy.
| Phase | Item | ERAS protocol |
|---|---|---|
| Preoperative | Patient and family counseling | Routine consultation for elective craniotomy + detailed instruction on ERAS workflow with a handbook given ≥1 wk prior to surgery |
| Functional status | Assessment of functional status and physical activity + progressive exercise prehabilitation 2 to 4 wk prior to surgery | |
| Nutrition | Nutritional assessment and consultation for BMI <18.5 or >24, serum albumin <3.5 g/dL | |
| Mental status | Hospital anxiety and depression assessment + psychiatric consultation as needed | |
| Management of comorbidity | Appropriate preoperative assessment and specialty consultation when necessary | |
| Respiratory preparation | Oral and nasal cavity care: mouthwash and nasal drops | |
| Physical exercise: chest movement, balloon blowing, abdominal breathing exercises, cough training, respiratory muscle training | ||
| High-risk factor (older age, past and concomitant cardiopulmonary diseases, estimated prolonged surgical time) intervention: mucolytics and expectorants | ||
| Smoking and alcohol abstinence | Abstinence for ≥4 wk prior to surgery | |
| Antithrombotic prophylaxis | Active/passive limb exercise, GCS, IPC starting from admission till discharge | |
| Intestinal preparation | Glycerine enema for chronic constipation or no defecation ≥2 d | |
| Preoperative fasting and oral carbohydrate loading | Fasting period of 6 h for solids and 2 h for clear fluids | |
| 400 mL of oral carbohydrate loading 2 h prior to surgery | ||
| Antimicrobial skin preparation | Washing hair with chlorhexidine | |
| Minimal shaving a 1- to 2-cm-wide strip along the planned incision immediately before surgery | ||
| Antibiotic prophylaxis with cefazolin within 30 min prior to skin incision | ||
| Discharge planning | Initiate discharge planning at the time of patient education to establish expectations and ensure smooth transition home + timely and responsive follow-up strategy | |
| Intraoperative | Microinvasive surgery | Minimally invasive approaches (e.g., keyhole surgery, endoscopic endonasal surgery), neuronavigation, electrophysiologic monitoring, hybrid operating room, awake craniotomy techniques, etc. |
| Anesthetic protocol | TIVA or combined intravenous-inhalation anesthesia with short-acting agents, avoiding isoflurane | |
| Intraoperative use of a depth of anesthesia monitor and sedation as light as possible | ||
| Hypothermia avoidance | Forced-air or electric heating pad + warmed fluid irrigation and infusion | |
| Goal-directed fluid balance | GDFR strategy + noninvasive cardiac output monitoring | |
| Scalp block and local incision anesthesia | Subcutaneous anesthesia with ropivacaine prior to incision and wound suturing | |
| Absorbable suture | Absorbable interrupted suture for dura, muscle and subcutaneous tissue, intradermal suture for skin incision, wound covered with sterile adhesive strips | |
| Restrictive surgical site drains | Restrict placement of surgical site drains unless deemed necessary | |
| If placed, remove as early as possible within 24 to 48 h | ||
| ICU and extubation | Avoid admission to ICU whenever possible | |
| Extubation at the end of surgery | ||
| Postoperative | Nonopioid analgesia | Preemptive analgesia: acetaminophen the night before surgery and on the morning of surgery |
| Intraoperative scalp block and local incision anesthesia + dexmedetomidine | ||
| Postoperative repeated assessments of pain VAS scores | ||
| Pain VAS score <4: no analgesia or oral minimal dose of nonopioid (acetaminophen, NSAIDs, and gabapentin) | ||
| Pain VAS score 4 to 6: oral or IV nonopioid | ||
| Pain VAS score ≥ 7: opioid ± PCA | ||
| PONV management | PONV prophylaxis: PONV risk score ≥ 3 (assessed by PONV Simple Risk Assessment Scale), dexamethasone, 5-HT receptor antagonist (tropisetron) | |
| Treatment: PONV VAS ≥5, repeat 5-HT receptor antagonist (tropisetron) | ||
| Severe or refractory cases: tropisetron + droperidol, promethazine | ||
| Diet | Oral free fluids: 4 h after surgery | |
| Light diet/polymeric nutritional supplement drink: 8 h after surgery as tolerated by the patient | ||
| Semiliquid/solid diet: 12 to 24 h after surgery | ||
| Ordinary diet. 24 to 48 h after surgery | ||
| Chewing gum: 3 times/d after surgery | ||
| Immunonutrition (arginine, omega-3 fatty acids, and ribonucleotides) for malnourished patients with cancer | ||
| Restrictive IV fluids | Rapid de-escalation of IV fluids | |
| Not routinely given after POD 1 unless the patient could not maintain urine output or blood pressure by oral intake | ||
| Completely discontinued by POD 3 whenever possible | ||
| Urinary catheter removal | Attempts to remove urinary catheter within POD 1 whenever possible | |
| Regular assessment of the need for maintaining the catheter | ||
| Encouraging voiding regimens + bladder scanning + early and aggressive mobilization to prevent urinary retention | ||
| Early mobilization and ambulation | Active management of postoperative fear of movement | |
| In-bed limb exercises: 6 h after surgery | ||
| Early ambulation: POD 1 | ||
| Delirium prevention | Intraoperative use of a depth of anesthesia monitor | |
| Avoiding anticholinergics, antipsychotics, and benzodiazepines | ||
| Regular assessment and nursing care | ||
| Glycemic control | Regular monitoring with insulin treatment as needed to maintain glycemic levels 180 to 200 mg/dL | |
| Discharge | Patient evaluation | Functional status, nutrition, mental status, anxiety and depression, pain VAS score |
| Pain management | Adequate pain control with oral nonopioid | |
| Nutrition | Oral nutrition without IV fluids | |
| Vital status and healing of surgical incision | No fever or signs of infection | |
| Satisfactory healing of surgical incision | ||
| Mobility | Independent mobility or mobility with minimal assistance | |
| Destination | Safe discharge home or to rehabilitation center | |
| Follow-up | Home + clinic follow-up | Timely and responsive follow-up with social media cellphone/website app + outpatient clinic visit |
| Functional status, pain medication use, late-onset complications, quality of life | ||
| Audit | Standardized audit and feedback | Data and safety monitoring to document process/outcome data, assess impact and encourage compliance |
BMI = body mass index, GCS = graduated compression stockings, GDFR = goal-directed fluid restriction, ICU = intensive care unit, IPC = intermittent pneumatic compression, IV = intravenous, NSAIDs = nonsteroidal anti-inflammatory drugs, PCA = patient-controlled analgesia, POD = postoperative day, PONV = postoperative nausea and vomiting, TIVA = total intravenous anesthetic, VAS = visual analog scale.
Outcome measures.
| Outcomes | Parameters, assessment technique/instrument |
|---|---|
| Objective outcomes | |
| Hospital LOS | |
| Postoperative complications | Surgical complications (e.g., SSI, intracranial infection, seizure, and hemorrhage) and nonsurgical complications (e.g., cardiovascular, respiratory, gastrointestinal complications, UTI, DVT, and VTE) |
| Mortality | |
| 30-d reoperation | |
| 30-d readmission | |
| Functional recovery status | Pulmonary function (vital capacity and peak expiratory flow rate) |
| Cardiovascular function (treadmill performance) | |
| Muscle strength (handgrip strength) | |
| Nutrition (BMI, serum albumin, and body composition) | |
| Time to tolerate diet (first water intake and oral liquid/solid food) | |
| Time to remove urinary catheter | |
| Mobility (time to ambulation, pedometer, and independent mobility) | |
| Overall functional status (KPS score) | |
| Analgesia consumption | Opioid versus nonopioid |
| Healthcare cost | |
| Patient-reported outcomes | |
| Pain | VAS score |
| PONV | VAS score |
| Fatigue/frailty | VAS score, FRAIL Scale |
| Anxiety and depression | Hospital Anxiety and Depression Scale |
| General health perceptions and quality of life | SF-36, EORTC QLQ-C30/BN20 |
| Patient satisfaction and comfort | Appropriate and validated questionnaire |
DVT = deep vein thrombosis, EORTC QLQ-C30/BN20 = European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire 30/Brain Cancer Module, KPS = Karnofsky performance status, LOS = length of stay, PONV = postoperative nausea and vomiting, SSI = surgical site infection, UTI = urinary tract infection, VAS = visual analog scale, VTE = venous thromboembolism.